Norway-founded humanoid robotics startup 1X opens a new 58,000-square-foot factory in Hayward, California, where it aims to build 100K robots by the end of 2027
Context & Ripple Effects
1X has progressed from a $23.5M Series A2 in 2023 to a $100M Series B in 2024, while later reporting indicated it was pursuing substantially larger financing. The Hayward site is the clearest operational step in that arc: moving from funding and product ambitions toward a stated manufacturing target.
The move lands amid an intensifying humanoid-robotics capital race. X Square Robot has raised significant funding and released an embodied-AI foundation model, while Figure has reportedly sought a far larger round, raising the stakes for companies to demonstrate not just models and prototypes but a credible route to production.
First-order effects
- 1X gains dedicated US manufacturing capacity and a concrete production objective of 100,000 robots by the end of 2027; its execution will now be judged against factory ramp-up, not only fundraising and product plans.
- The company must convert its financing and humanoid-robot development work into repeatable manufacturing processes, supply arrangements, and deployments capable of supporting that target.
Second-order effects
- Rival humanoid startups face greater pressure to pair large funding rounds and AI-model announcements with credible manufacturing plans, especially for access to customers and future capital.
- A high-volume target shifts attention to the production ecosystem around humanoids—components, integration, testing, and deployment support—because bottlenecks in any of those areas can constrain output even when robot software advances.
Third-order effects
- If multiple well-funded humanoid developers make the transition to factories, the sector’s competitive divide will increasingly be determined by manufacturing reliability and deployment economics rather than by prototype demonstrations alone.
- The stated scale remains an ambition, not evidence of achieved volume; whether such facilities can reach repeatable output will determine whether humanoid robotics becomes a production-led market or remains primarily a capital- and R&D-led one.
The trend: Humanoid robotics is entering a manufacturing-validation phase in which companies must translate abundant venture backing and embodied-AI progress into scalable physical production.